Richard Auchus, MD, PhD, professor of pharmacology and internal medicine, University of Michigan.
Richard Auchus, MD, on how crinecerfont is changing CAH treatment
Richard Auchus, MD, PhD, discusses how crinecerfont is improving CAH care and easing the transition from pediatric to adult management.
Richard Auchus, MD: Crinecerfont's positive weight-related outcomes in children with CAH
Richard Auchus, MD, PhD, highlights data showing that crinecerfont use in children with CAH can improve metabolic outcomes.